Risk factors for the development of systemic sclerosis: a systematic review of the literature
- PMID: 31431978
- PMCID: PMC6649937
- DOI: 10.1093/rap/rky041
Risk factors for the development of systemic sclerosis: a systematic review of the literature
Abstract
Objectives: Although numerous studies have investigated the roles of various genetic, epigenetic and environmental factors that may impact its aetiology, SSc is still regarded as an idiopathic disease. Given that there is significant heterogeneity in what has been proposed to influence the development of SSc, this systematic review was conducted to assess the impacts of different factors on the aetiology of scleroderma.
Methods: The search was performed in the PubMed, CINAHL and SCOPUS databases on 17 May 2017. Any study that made explicit reference to scleroderma or SSc that had information about the risk factors or epidemiology of the disease was included. The extracted outcome variables were prevalence, gender preponderance, geographical distribution, family history and various proposed environmental risk factors.
Results: One thousand five hundred and seventy-four articles were screened for eligibility. Thirty-four articles were eligible for the systematic literature review.
Conclusion: Age between 45 and 64 years, female sex, positive family history and exposure to silica were found to be risk factors. There were conflicting findings regarding the impact of exposure to organic solvents and microchimerism. No relationship between infectious agents, alcohol consumption or cigarette smoking and the development of SSc was identified.
Keywords: epidemiology; risk factors; scleroderma; systemic sclerosis.
Figures
Similar articles
-
Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence.Epidemiol Prev. 2018 May-Aug;42(3-4 Suppl 1):1-34. doi: 10.19191/EP18.3-4.S1.P001.057. Epidemiol Prev. 2018. PMID: 30066535 Review. English.
-
Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature.Autoimmun Rev. 2014 Feb;13(2):151-6. doi: 10.1016/j.autrev.2013.10.002. Epub 2013 Oct 12. Autoimmun Rev. 2014. PMID: 24129037 Review.
-
High prevalence and risk factors for osteoporosis in 1839 patients with systemic sclerosis: a systematic review and meta-analysis.Clin Rheumatol. 2023 Apr;42(4):1087-1099. doi: 10.1007/s10067-022-06460-0. Epub 2022 Dec 7. Clin Rheumatol. 2023. PMID: 36474110
-
Sex hormones and sex hormone-targeting therapies in systemic sclerosis: A systematic literature review.Semin Arthritis Rheum. 2020 Feb;50(1):140-148. doi: 10.1016/j.semarthrit.2019.07.007. Epub 2019 Jul 20. Semin Arthritis Rheum. 2020. PMID: 31362894
-
Ocular involvement in systemic sclerosis: A systematic literature review, it's not all scleroderma that meets the eye.Semin Arthritis Rheum. 2019 Aug;49(1):119-125. doi: 10.1016/j.semarthrit.2018.12.007. Epub 2018 Dec 28. Semin Arthritis Rheum. 2019. PMID: 30660382
Cited by
-
Juvenile systemic sclerosis - observations of one clinical centre.Reumatologia. 2021;59(6):367-372. doi: 10.5114/reum.2021.112350. Epub 2022 Jan 12. Reumatologia. 2021. PMID: 35079180 Free PMC article.
-
Association Between Lipid Profile and Risk of Incident Systemic Sclerosis: A Nationwide Population-Based Study.Clin Epidemiol. 2023 Nov 29;15:1095-1107. doi: 10.2147/CLEP.S427881. eCollection 2023. Clin Epidemiol. 2023. PMID: 38050603 Free PMC article.
-
Risk of kidney failure in patients with systemic sclerosis: a nationwide population-based study.RMD Open. 2023 Nov;9(4):e003490. doi: 10.1136/rmdopen-2023-003490. RMD Open. 2023. PMID: 37945288 Free PMC article.
-
HIV-Associated Systemic Sclerosis: Literature Review and a Rare Case Report.Int J Environ Res Public Health. 2022 Aug 15;19(16):10066. doi: 10.3390/ijerph191610066. Int J Environ Res Public Health. 2022. PMID: 36011703 Free PMC article. Review.
-
Maternal-fetal outcomes in patients with immune-mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system.EClinicalMedicine. 2024 Feb 1;68:102435. doi: 10.1016/j.eclinm.2024.102435. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38586478 Free PMC article.
References
-
- Fett N. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies. Clin Dermatol 2013;31:432–7. - PubMed
-
- De Silva U, Parish LC.. Historical approach to scleroderma. Clin Dermatol 1994;12:201–5. - PubMed
-
- Benedek TG, Rodnan GP.. The early history and nomenclature of scleroderma and of its differentiation from sclerema neonatorum and scleroedema. Semin Arthritis Rheum 1982;12:52–67. - PubMed
-
- Silman AJ, Newman J.. Genetic and environmental factors in scleroderma. Curr Opin Rheumatol 1994;6:607–11. - PubMed
-
- Zhao JH, Duan Y, Wang YJ. et al. The influence of different solvents on systemic sclerosis: an updated meta-analysis of 14 case-control studies. J Clin Rheumatol 2016;22:253–9. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources